ESR1 and breast carcinoma: Risk factors, including high tumour grade, large tumour size, positive lymph node, and Estrogen receptor (ER) negative status, have been shown to be more prevalent in younger breast cancer patients, leading some to suggest that breast cancer in younger women represents a distinct clinical entity[4].